Nurix Therapeutics (NRIX) Cash from Investing Activities Growth (1y) (2020 - 2026)
Nurix Therapeutics (NRIX) Cash from Investing Activities Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Nurix Therapeutics | 2.64 Bn | 2.19 Bn | - | 30.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 30.07% |
| Feb 28, 2026 | -584.96% |
| Nov 30, 2025 | 100.25% |
| Aug 31, 2025 | 336.54% |
| May 31, 2025 | 154.55% |
| Feb 28, 2025 | -28.10% |
| Nov 30, 2024 | -879.73% |
| Aug 31, 2024 | -193.69% |
| May 31, 2024 | -399.03% |
| Feb 29, 2024 | 121.02% |
| Nov 30, 2023 | -126.13% |
| Aug 31, 2023 | 136.11% |
| May 31, 2023 | 1,019.85% |
| Feb 28, 2023 | -59.86% |
| Nov 30, 2022 | 250.61% |
| Aug 31, 2022 | -415.71% |
| May 31, 2022 | 91.66% |
| Feb 28, 2022 | 1,777.04% |
| Nov 30, 2021 | 70.68% |
| Aug 31, 2021 | 88.68% |